Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
merck
national blog main
2
×
new york blog main
2
×
raleigh-durham blog main
san diego blog main
san francisco
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
10x genomics
antibiotics
arvinas
astellas pharma
astrazeneca
becton dickinson
boston
boston blog main
boston top stories
boulder/denver
boulder/denver blog main
boulder/denver top stories
cancer
cancer diagnostics
carbapenem-resistant enterobacteriaceae
celgene
clinical trials
deals
detroit
detroit blog main
detroit top stories
diagnostic device
drugs
entasis therapeutics
fda
gritstone oncology
guardant health
idiopathic pulmonary fibrosis (ipf)
What
company
2
×
make
2
×
adding
aims
biotechs
chose
close
deal
decisions
device
diagnostic
diagnostics
expand
firms
fold
help
ipo
ipos
life
medical
nanostring
open
physicians
q
quarter
reach
science
technology
tests
treatment
veracyte
way
week
window
Language
unset
Current search:
company
×
" national blog main "
×
" new york blog main "
×
make
×
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way